glp-1 drugs overview Market Overview: Agonists and the Obesity Market | Blog GLP-1 Receptor Agonists and Research
Description
Even minimal weight loss (1 kg) decreases the risk of heart failure in T2DM patients by 5.9% [90]
Weight gain is influenced by many factors, with poor diet and lifestyle habits often playing a major role in the development of obesity
Compounded drugs are created from scratch by a pharmacist, usually when a patient cannot be helped by an FDA-approved drug
1 For patients who do not achieve their target A1C with metformin, the Diabetes Canada 2018 guidelines recommend selecting add-on therapy based on individual patient characteristics
